Candel Therapeutics (CADL) Earnings Date & Reports

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CADL is expected to report earnings to fall 408.08% to -40 cents per share on September 03

Candel Therapeutics CADL Stock Earnings Reports

Q2'25

Est.

$-0.40

Q1'25

Beat

by $0.50

Q4'24

Missed

by $0.10

Q4'23

Missed

by $0.20

Q3'23

Missed

by $0.10

The last earnings report on May 13 showed earnings per share of 12 cents, beating the estimate of -37 cents. With 1.10M shares outstanding, the current market capitalization sits at 293.10M.

View a ticker or compare two or three

Compare

CADL